Search

everythinglearnresearchcommunity

for

Search:↓

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Tertiary lymphoid structures are important in immunotherapy and need more research.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

B cells can both help and hinder the body's defense against melanoma.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Thymosin beta-4 promotes hair growth in mice.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Enhancing Tregs can protect against alopecia areata.

Thymosin β4 and VEGF are important for organ function and may help with blood vessel formation.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The skin produces and responds to thyroid-stimulating hormone, which is controlled by other thyroid-related hormones.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

The role of γδT-cells in causing alopecia areata remains unclear.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.